Home
SRZN
SRZN News

Latest Surrozen Inc. (SRZN) News on May 20, 2025

GlobeNewswire

6 days ago

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

GlobeNewswire

10 days ago

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire

2 months ago

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases

Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation

GlobeNewswire

6 months ago

Surrozen to Present at Upcoming Healthcare Investor Conferences

GlobeNewswire

6 months ago

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

GlobeNewswire

7 months ago

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

GlobeNewswire

8 months ago

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky

Simply Wall St.

9 months ago

Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

GlobeNewswire

9 months ago

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

GlobeNewswire

a year ago

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

Business Wire

a year ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Business Wire

a year ago

Form 8.3 - International Paper Company

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

GlobeNewswire

a year ago

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

GlobeNewswire

a year ago

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire

a year ago

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Surrozen Provides First Quarter 2024 Financial Results and Business Update

GlobeNewswire

a year ago

Surrozen Provides First Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

GlobeNewswire

a year ago

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

GlobeNewswire

a year ago

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

Vuzix Announces That NTT QONOQ Now Supports the Use of Its NTT XR Real Support Solution on Vuzix M400 Smart Glasses

PR Newswire

a year ago

Vuzix Announces That NTT QONOQ Now Supports the Use of Its NTT XR Real Support Solution on Vuzix M400 Smart Glasses

Meta Materials Announces Preliminary Results for The Fourth Quarter 2023

ACCESSWIRE

a year ago

Meta Materials Announces Preliminary Results for The Fourth Quarter 2023

Thomson Reuters StreetEvents

a year ago

Q3 2024 GSI Technology Inc Earnings Call

Associated Press Finance

a year ago

GSI Technology: Fiscal Q3 Earnings Snapshot

GSI Technology, Inc. Reports Third Quarter Fiscal 2024 Results

GlobeNewswire

a year ago

GSI Technology, Inc. Reports Third Quarter Fiscal 2024 Results

Alternus Clean Energy Enters Strategic Alliance with Hover Energy

GlobeNewswire

a year ago

Alternus Clean Energy Enters Strategic Alliance with Hover Energy

LiveOne's Subsidiary LiveOne Brands' Birthday Sex Wine Sells Out in First Week of Pre-Sale

NewMediaWire

a year ago

LiveOne's Subsidiary LiveOne Brands' Birthday Sex Wine Sells Out in First Week of Pre-Sale

Mullen Invoices and Delivers 130 Additional Class 1 EV Cargo Vans to Randy Marion Automotive Group for $4,372,550.00

GlobeNewswire

a year ago

Mullen Invoices and Delivers 130 Additional Class 1 EV Cargo Vans to Randy Marion Automotive Group for $4,372,550.00

Surrozen Provides Corporate Update on Clinical Programs

GlobeNewswire

a year ago

Surrozen Provides Corporate Update on Clinical Programs

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

SeaStar Medical Appoints David A. Green as Chief Financial Officer

GlobeNewswire

a year ago

SeaStar Medical Appoints David A. Green as Chief Financial Officer

3 Stocks Set to Soar 68% to 200% Higher

InvestorPlace

a year ago

3 Stocks Set to Soar 68% to 200% Higher

Certain DWS Closed-End Funds Declare Monthly Distributions

Business Wire

a year ago

Certain DWS Closed-End Funds Declare Monthly Distributions

Knightscope Emergency Communications Sales Continue with Three New Orders

Business Wire

a year ago

Knightscope Emergency Communications Sales Continue with Three New Orders

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

GlobeNewswire

a year ago

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

Newswire Named Leader in Press Release Distribution in G2's Winter 2024 Report

ACCESSWIRE

a year ago

Newswire Named Leader in Press Release Distribution in G2's Winter 2024 Report

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

GlobeNewswire

a year ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

Reuters

a year ago

UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy

Reuters

a year ago

US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

GlobeNewswire

a year ago

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Business Wire

a year ago

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Best Value Stocks to Buy for December 13th

Zacks

a year ago

Best Value Stocks to Buy for December 13th

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

PR Newswire

a year ago

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

Rocky Mountain Chocolate Appoints Steve Craig to Its Board of Directors

GlobeNewswire

a year ago

Rocky Mountain Chocolate Appoints Steve Craig to Its Board of Directors

Stran & Company to Present at the Investor Summit on December 7th

GlobeNewswire

a year ago

Stran & Company to Present at the Investor Summit on December 7th

Cooper-Standard Holdings' (NYSE:CPS) investors will be pleased with their splendid 181% return over the last year

Simply Wall St.

a year ago

Cooper-Standard Holdings' (NYSE:CPS) investors will be pleased with their splendid 181% return over the last year

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

InvestorPlace

a year ago

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

GlobeNewswire

a year ago

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Dakota Gold Corp. Issues Correction to November 21, 2023 News Release Announced Earlier Today

Newsfile

a year ago

Dakota Gold Corp. Issues Correction to November 21, 2023 News Release Announced Earlier Today

Golden Matrix Achieves Record Revenues Exceeding $44 Million in Fiscal 2023

GlobeNewswire

a year ago

Golden Matrix Achieves Record Revenues Exceeding $44 Million in Fiscal 2023

PR Newswire

2 years ago

ZENVIA Reports Q3 2023 and 9M 2023 Results

Thomson Reuters StreetEvents

2 years ago

Q3 2023 DURECT Corp Earnings Call

Associated Press Finance

2 years ago

Durect: Q3 Earnings Snapshot

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

PR Newswire

2 years ago

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Simply Wall St.

2 years ago

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Monroe Capital Corporation (NASDAQ:MRCC) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Monroe Capital Corporation (NASDAQ:MRCC) Q3 2023 Earnings Call Transcript

Virgin Galactic, Astra Space: Space flight stocks soar high

Yahoo Finance Video

2 years ago

Virgin Galactic, Astra Space: Space flight stocks soar high

Societal CDMO Inc (SCTL) Reports Q3 2023 Financial Results Amidst Strategic Reorganization

GuruFocus.com

2 years ago

Societal CDMO Inc (SCTL) Reports Q3 2023 Financial Results Amidst Strategic Reorganization

Surrozen Provides Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Surrozen Provides Third Quarter 2023 Financial Results

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023

Newsfile

2 years ago

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023

Established Managed Investment Solutions Team Joins Westwood Holdings Group

GlobeNewswire

2 years ago

Established Managed Investment Solutions Team Joins Westwood Holdings Group

Associated Press Finance

2 years ago

NCS Multistage: Q3 Earnings Snapshot

NCS Multistage Holdings, Inc. Announces Third Quarter 2023 Results

GlobeNewswire

2 years ago

NCS Multistage Holdings, Inc. Announces Third Quarter 2023 Results

Share on Social Networks: